#$%^&*AU2015264811A120160107.pdf#####ABSTRACT The invention relates to a method of treating ocular amyloidosis by reducing TTR expression in a subject by administering a double-stranded ribonucleic acid (dsRNA) that targets a TTR gene to the retinal pigment epithelium of the subject.1/32 C9C 9Z 19 < cv -u -~ 00 a-t Uz CD -CD C ) C>D DC 00 00 co CC [lwuifd]